SCHEMBL7019645

SCHEMBL7019645

CN(C)CCN(C)c1nc2[c]cccc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
BCHE P06276 1/20 0.40
KCNMA1 Q12791 1/20 0.36
ALDH1A1 P00352 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTR6 P50406 1/20 0.31
PPARG P37231 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7445522 0.87 LMNA (0.35) ACHEBCHEALDH1A1LMNACYP1A2
SCHEMBL7021973 0.87 BCHE (0.34) ACHEBCHELMNACYP1A2CYP2D6
SCHEMBL7014749 0.81 LMNA (0.33) ACHEBCHEALDH1A1LMNACYP1A2
SCHEMBL7016988 0.74 CSNK2A2 (0.42) ACHEBCHEHRH3CYP2C19HTR2C
SCHEMBL7019229 0.74 BCHE (0.38) ACHEBCHEALDH1A1LMNACYP2D6
SCHEMBL7021972 0.73 TAAR1 (0.30)
SCHEMBL7963781 0.71 MEN1 (0.43) ACHEBCHEKCNMA1ALDH1A1HRH3
SCHEMBL8470141 0.69
SCHEMBL211307 0.69 ALDH1A1 (0.43) ALDH1A1
SCHEMBL7021216 0.68 DDAH1 (0.53) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051415-B1 BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-09-24 EP disclosed
US-6495542-B1 SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-17 US disclosed